{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:02:51Z","timestamp":1792206171542,"version":"4.4.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T00:00:00Z","timestamp":1762041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100024890","name":"Institut de la statistique du Qu\u00e9bec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021570","name":"Strategy for Patient-Oriented Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021570","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT 156043"],"award-info":[{"award-number":["PJT 156043"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jns.2025.123746","type":"journal-article","created":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:10:21Z","timestamp":1762103421000},"page":"123746","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Association between benzodiazepines and dementia: A case-control study from Canadian health surveys and medico-administrative databases"],"prefix":"10.1016","volume":"479","author":[{"given":"Diego","family":"Legrand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Roberge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Vanasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bocti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2025.123746_bb0005","series-title":"World Alzheimer Report 2021: Journey through the Diagnosis of Dementia","author":"Gauthier","year":"2021"},{"key":"10.1016\/j.jns.2025.123746_bb0010","series-title":"Dementia (Fact Sheet)","author":"World Health Organization","year":"2025"},{"issue":"8","key":"10.1016\/j.jns.2025.123746_bb0015","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.arcmed.2012.10.006","article-title":"The macroeconomics of dementia\u2014will the world economy get Alzheimer\u2019s disease?","volume":"43","author":"Banerjee","year":"2012","journal-title":"Arch. Med. Res."},{"issue":"9","key":"10.1016\/j.jns.2025.123746_bb0020","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S1474-4422(23)00128-X","article-title":"The complex pathway between amyloid \u03b2 and cognition: implications for therapy","volume":"22","author":"Jagust","year":"2023","journal-title":"Lancet Neurol."},{"issue":"3\u20134","key":"10.1016\/j.jns.2025.123746_bb0025","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000486546","article-title":"A systematic review and meta-analysis of the effectiveness of acetylcholinesterase inhibitors and memantine in treating the cognitive symptoms of dementia","volume":"45","author":"Knight","year":"2018","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"4","key":"10.1016\/j.jns.2025.123746_bb0030","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/brain\/awu035","article-title":"Compensatory mechanisms in higher-educated subjects with Alzheimer\u2019s disease: a study of 20 years of cognitive decline","volume":"137","author":"Amieva","year":"2014","journal-title":"Brain"},{"issue":"10452","key":"10.1016\/j.jns.2025.123746_bb0035","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(24)01296-0","article-title":"Dementia prevention, intervention, and care: 2024 report of the lancet standing commission","volume":"404","author":"Livingston","year":"2024","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jns.2025.123746_bb0040","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1017\/S1121189X00000531","article-title":"Patterns of benzodiazepine use in a Canadian population sample","volume":"18","author":"Esposito","year":"2009","journal-title":"Epidemiol. Psichiatr. Soc."},{"issue":"3","key":"10.1016\/j.jns.2025.123746_bb0045","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s40263-016-0404-x","article-title":"Benzodiazepine use and risk of developing Alzheimer\u2019s disease: a case-control study based on Swiss claims data","volume":"31","author":"Bi\u00e9try","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jns.2025.123746_bb0050","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g5205","article-title":"Benzodiazepine use and risk of Alzheimer\u2019s disease: case-control study","volume":"349","author":"Billioti de Gage","year":"2014","journal-title":"BMJ"},{"issue":"10","key":"10.1016\/j.jns.2025.123746_bb0055","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/jech-2011-200314","article-title":"Benzodiazepine use and risk of dementia: evidence from the Caerphilly prospective study (CaPS)","volume":"66","author":"Gallacher","year":"2012","journal-title":"J. Epidemiol. Community Health"},{"key":"10.1016\/j.jns.2025.123746_bb0060","article-title":"Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population-based study","volume":"352","author":"Gray","year":"2016","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.jns.2025.123746_bb0065","first-page":"339","article-title":"Deprescribing benzodiazepine receptor agonists: evidence-based clinical practice guideline","volume":"64","author":"Pottie","year":"2018","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.jns.2025.123746_bb0070","series-title":"Canadian Guidelines on Benzodiazepine Receptor Agonist Use Disorder among Older Adults","author":"Conn","year":"2019"},{"key":"10.1016\/j.jns.2025.123746_bb0075","series-title":"Benzodiazepine and Z-drug safety guideline","author":"Kaiser Foundation Health Plan of Washington","year":"2022"},{"issue":"680","key":"10.1016\/j.jns.2025.123746_bb0080","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3399\/bjgp19X701753","article-title":"Prescribing benzodiazepines in general practice","volume":"69","author":"Kennedy","year":"2019","journal-title":"Br. J. Gen. Pract."},{"key":"10.1016\/j.jns.2025.123746_bb0085","series-title":"Johns Hopkins Psychiatry Guide: Benzodiazepines","author":"Kim","year":"2016"},{"key":"10.1016\/j.jns.2025.123746_bb0090","series-title":"Hypnotics. Key Therapeutic Topic KTT6","author":"National Institute for Health and Care Excellence (NICE)","year":"2015"},{"key":"10.1016\/j.jns.2025.123746_bb0095","series-title":"Standard of Practice: Prescribing Benzodiazepines & Z-Drugs (Including Zopiclone & Other Drugs)","author":"College of Physicians & Surgeons of Manitoba","year":"2020"},{"key":"10.1016\/j.jns.2025.123746_bb0100","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1186\/s12889-019-6933-8","article-title":"Prevalence of prescribed benzodiazepine long-term use in the French general population according to sociodemographic and clinical factors: findings from the CONSTANCES cohort","volume":"19","author":"Airagnes","year":"2019","journal-title":"BMC Public Health"},{"issue":"11","key":"10.1016\/j.jns.2025.123746_bb0105","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1001\/jamainternmed.2018.2413","article-title":"Factors associated with long-term benzodiazepine use among older adults","volume":"178","author":"Gerlach","year":"2018","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.jns.2025.123746_bb0110","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12877-021-02213-x","article-title":"The prevalence and prescribing patterns of benzodiazepines and Z-drugs in older nursing home residents in different European countries and Israel: retrospective results from the EU SHELTER study","volume":"21","author":"Luka\u010di\u0161inov\u00e1","year":"2021","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.jns.2025.123746_bb0115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.drugalcdep.2019.02.033","article-title":"The epidemiology of benzodiazepine misuse: a systematic review","volume":"200","author":"Votaw","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.jns.2025.123746_bb0120","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1017\/S0714980812000232","article-title":"Correlates of potentially inappropriate prescriptions of benzodiazepines among older adults: results from the ESA study","volume":"31","author":"Pr\u00e9ville","year":"2012","journal-title":"Can. J. Aging"},{"issue":"3","key":"10.1016\/j.jns.2025.123746_bb0125","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archneurol.2011.31","article-title":"Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment","volume":"68","author":"Wilson","year":"2011","journal-title":"Arch. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2025.123746_bb0130","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.medcli.2020.02.006","article-title":"Association between benzodiazepine use and development of dementia","volume":"156","author":"Aldaz","year":"2021","journal-title":"Med. Clin. (Barc.)"},{"issue":"2","key":"10.1016\/j.jns.2025.123746_bb0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.maturitas.2013.03.001","article-title":"Benzodiazepine and dementia: a time for reflection","volume":"75","author":"Bocti","year":"2013","journal-title":"Maturitas"},{"issue":"5","key":"10.1016\/j.jns.2025.123746_bb0140","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/gerona\/glab241","article-title":"Use of benzodiazepines and risk of incident dementia: a retrospective cohort study","volume":"77","author":"Gerlach","year":"2022","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"issue":"10","key":"10.1016\/j.jns.2025.123746_bb0145","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s40264-015-0319-3","article-title":"Benzodiazepine use and risk of developing Alzheimer\u2019s disease or vascular dementia: a case-control analysis","volume":"38","author":"Imfeld","year":"2015","journal-title":"Drug Saf."},{"issue":"2","key":"10.1016\/j.jns.2025.123746_bb0150","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/ageing\/afn277","article-title":"The risk of cognitive impairment in older community-dwelling women after benzodiazepine use","volume":"38","author":"Lagnaoui","year":"2009","journal-title":"Age Ageing"},{"issue":"6","key":"10.1016\/j.jns.2025.123746_bb0155","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1176\/appi.ajp.2019.19030315","article-title":"Associations of benzodiazepines, Z-drugs, and other anxiolytics with subsequent dementia in patients with affective disorders: a nationwide cohort and nested case-control study","volume":"177","author":"Osler","year":"2020","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.jns.2025.123746_bb0160","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7150\/ijms.16185","article-title":"Association between benzodiazepine use and dementia: data mining of different medical databases","volume":"13","author":"Takada","year":"2016","journal-title":"Int. J. Med. Sci."},{"issue":"2","key":"10.1016\/j.jns.2025.123746_bb0165","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/WAD.0000000000000099","article-title":"Benzodiazepine use and cognitive decline in elderly with normal cognition","volume":"30","author":"Zhang","year":"2016","journal-title":"Alzheimer Dis. Assoc. Disord."},{"issue":"5","key":"10.1016\/j.jns.2025.123746_bb0170","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/ana.21509","article-title":"Prodromal Alzheimer\u2019s disease: successive emergence of the clinical symptoms","volume":"64","author":"Amieva","year":"2008","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2025.123746_bb0175","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1017\/S1041610217001880","article-title":"Affective and emotional dysregulation as pre-dementia risk markers: exploring the mild behavioral impairment symptoms of depression, anxiety, irritability, and euphoria","volume":"30","author":"Ismail","year":"2018","journal-title":"Int. Psychogeriatr."},{"key":"10.1016\/j.jns.2025.123746_bb0180","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1007\/s00415-024-12380-7","article-title":"Sleep characteristics and risk of Alzheimer\u2019s disease: a systematic review and meta-analysis of longitudinal studies","volume":"271","author":"Wang","year":"2024","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2025.123746_bb0185","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyaa167","article-title":"Cohort profile: the care trajectories\u2014enriched data (TorSaDE) cohort","volume":"50","author":"Vanasse","year":"2021","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.jns.2025.123746_bb0190","series-title":"Surveillance de la maladie d\u2019Alzheimer et des maladies apparent\u00e9es: \u00e9tude de faisabilit\u00e9 \u00e0 partir des fichiers administratifs","author":"Kr\u00f6ger","year":"2015"},{"issue":"5","key":"10.1016\/j.jns.2025.123746_bb0195","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/YIC.0000000000000312","article-title":"Benzodiazepine exposure in subjects with incident Alzheimer\u2019s disease and related syndromes in France: a longitudinal study 2011\u20132017","volume":"35","author":"Poncet","year":"2020","journal-title":"Int. Clin. Psychopharmacol."},{"issue":"5","key":"10.1016\/j.jns.2025.123746_bb0200","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/psyg.12239","article-title":"Association between high cumulative dose of benzodiazepine in Chinese patients and risk of dementia: a preliminary retrospective case-control study","volume":"17","author":"Chan","year":"2017","journal-title":"Psychogeriatrics"},{"issue":"2","key":"10.1016\/j.jns.2025.123746_bb0205","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/acps.12909","article-title":"The risk of Alzheimer\u2019s disease associated with benzodiazepines and related drugs: a nested case-control study","volume":"138","author":"Tapiainen","year":"2018","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.jns.2025.123746_bb0210","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jclinepi.2023.09.014","article-title":"The use of the E-value for sensitivity analysis","volume":"163","author":"Chung","year":"2023","journal-title":"J. Clin. Epidemiol."},{"issue":"5","key":"10.1016\/j.jns.2025.123746_bb0215","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/ije\/dyaa094","article-title":"Commentary: developing best-practice guidelines for the reporting of E-values","volume":"49","author":"VanderWeele","year":"2020","journal-title":"Int. J. Epidemiol."},{"issue":"4","key":"10.1016\/j.jns.2025.123746_bb0220","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3233\/JAD-201319","article-title":"Association between the use of hypnotics and the risk of Alzheimer\u2019s disease","volume":"81","author":"Jeong","year":"2021","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"6","key":"10.1016\/j.jns.2025.123746_bb0225","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jalz.2015.10.006","article-title":"Benzodiazepine, psychotropic medication, and dementia: a population-based cohort study","volume":"12","author":"Shash","year":"2016","journal-title":"Alzheimers Dement."},{"issue":"7","key":"10.1016\/j.jns.2025.123746_bb0230","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/JGP.0b013e3181a65210","article-title":"The association between dementia and long-term use of benzodiazepine in the elderly: nested case-control study using claims data","volume":"17","author":"Wu","year":"2009","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jns.2025.123746_bb0235","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jad.2019.04.067","article-title":"The effect of psychotropic drugs on cortical excitability and plasticity measured with transcranial magnetic stimulation: implications for psychiatric treatment","volume":"253","author":"Minzenberg","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jns.2025.123746_bb0240","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1749-6632.2000.tb05559.x","article-title":"A plasticity-based theory of the pathogenesis of Alzheimer\u2019s disease","volume":"924","author":"Mesulam","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jns.2025.123746_bb0245","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsaf168","article-title":"Effect of chronic benzodiazepine and benzodiazepine receptor agonist use on sleep architecture and brain oscillations in older adults with chronic insomnia","author":"Barbaux","year":"2025","journal-title":"Sleep"},{"key":"10.1016\/j.jns.2025.123746_bb0250","article-title":"Insomnia and risk of all-cause dementia: a systematic review and meta-analysis","volume":"20","author":"Meng","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2025.123746_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2025.1624813","article-title":"Chronic benzodiazepine treatment triggers gephyrin scaffold destabilization and GABA_AR subsynaptic reorganization","volume":"19","author":"Chapman","year":"2025","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.jns.2025.123746_bb0260","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neulet.2015.12.048","article-title":"Chronic benzodiazepine treatment decreases spine density in cortical pyramidal neurons","volume":"613","author":"Curto","year":"2016","journal-title":"Neurosci. Lett."},{"issue":"3","key":"10.1016\/j.jns.2025.123746_bb0265","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41593-022-01013-9","article-title":"Long-term diazepam treatment enhances microglial spine engulfment and impairs cognitive performance via the mitochondrial 18 kDa translocator protein (TSPO)","volume":"25","author":"Shi","year":"2022","journal-title":"Nat. Neurosci."},{"issue":"1","key":"10.1016\/j.jns.2025.123746_bb0270","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13195-021-00949-7","article-title":"Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer\u2019s disease","volume":"14","author":"Creese","year":"2022","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"1","key":"10.1016\/j.jns.2025.123746_bb0275","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s13311-019-00801-9","article-title":"Benzodiazepines, Z-hypnotics, and risk of dementia: special considerations of half-lives and concomitant use","volume":"17","author":"Tseng","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"8","key":"10.1016\/j.jns.2025.123746_bb0280","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00228-024-03677-7","article-title":"Failure to reduce benzodiazepine prescriptions through the implementation of a psychological intervention for insomnia in an Italian mental health service","volume":"80","author":"D\u2019Avanzo","year":"2024","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jns.2025.123746_bb0285","article-title":"Tackling benzodiazepine misuse","volume":"362","author":"Hayhoe","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jns.2025.123746_bb0290","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1186\/s12877-022-03579-2","article-title":"Diagnostic accuracy of linked administrative data for dementia diagnosis in community-dwelling older men in Australia","volume":"22","author":"Chow","year":"2022","journal-title":"BMC Geriatr."},{"key":"10.1016\/j.jns.2025.123746_bb0295","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12913-020-06032-5","article-title":"Effect of socio-demographic and health factors on the association between multimorbidity and acute care service use: population-based survey linked to health administrative data","volume":"21","author":"Fisher","year":"2021","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.jns.2025.123746_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fepid.2022.1054485","article-title":"Agreement between self-report and administrative health data on occurrence of non-cancer chronic disease among participants of the BC generations project","volume":"2","author":"Darvishian","year":"2022","journal-title":"Front. Epidemiol."},{"key":"10.1016\/j.jns.2025.123746_bb0305","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1186\/1471-2458-11-837","article-title":"Discrepancies between survey and administrative data on the use of mental health services in the general population: findings from a study conducted in Qu\u00e9bec","volume":"11","author":"Drapeau","year":"2011","journal-title":"BMC Public Health"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25003661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X25003661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T11:02:14Z","timestamp":1773313334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X25003661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":61,"alternative-id":["S0022510X25003661"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2025.123746","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between benzodiazepines and dementia: A case-control study from Canadian health surveys and medico-administrative databases","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2025.123746","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123746"}}